Product Information
TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3713 per EA under NDC 68462084013. Its NADAC has been published 248 times since Sep 29, 2021.
Strength
12.5; 40 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462084013
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202544On Market Since
3/4/2019
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has been published 248 times since Sep 29, 2021, and over the history we have for it it has declined 81.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3713 per EA |
|---|---|
| All-time high | $2.0330 (Oct 13, 2021) |
| All-time low | $0.2777 (Nov 20, 2024) |
| 52-week high | $0.4067 |
| 52-week low | $0.3484 |
| Median price | $0.5147 |
| Average price | $0.6592 |
| Largest weekly change | +83.5% (Nov 22, 2023) |
| Weeks tracked | 248 |
| Tracking since | Sep 29, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3713 per EA (NDC 68462084013), effective Jun 24, 2026.
How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has declined 81.7%. It has been tracked across 248 weekly CMS publications since Sep 29, 2021.
What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
Since Sep 29, 2021, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has ranged from a low of $0.2777 (Nov 20, 2024) to a high of $2.0330 (Oct 13, 2021), with a median of $0.5147 per EA.
Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, but none are currently priced below it.
Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB (NDC 68462084013) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification